Skip to main content
. 2017 Jun 27;8(53):90905–90915. doi: 10.18632/oncotarget.18677

Figure 5. EphB4 downregulation enhanced andrographolide’s promotion of As2O3 anti-tumor effects in vivo.

Figure 5

(A) The levels of EphB4 and VEGFR1 were analyzed by western blot assay. (B) Quantitative results by western blot. (C) Immunohistochemical validation of EphB4 in representative HCC and control tissue sections stained with anti-EphB4 antibody. Each experiment was independently repeated more than three times.